The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation
Open accessAbstract
Objectives The purpose of this study was to assess the safety and efficacy of left atrial appendage (LAA) closure in nonvalvular atrial fibrillation (AF) patients ineligible for warfarin therapy.Background The PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that LAA closure with the Watchman device (Boston Scientific, Natick, Massachusetts) was noninferior to warfarin therapy. However, the PROTECT AF trial only included patients who were candidates for warfarin, and even patients randomly assigned to the LAA closure arm received concomitant warfarin for 6 weeks after Watchman implantation.Methods A multicenter, prospective, nonrandomized study was conducted of LAA closure with the Watchman device in 150 patients with nonvalvular AF and CHADS₂ (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and prior stroke or transient ischemic attack) score ≥1, who were considered ineligible for warfarin. The primary efficacy endpoint was the combined events of ischemic stroke, hemorrhagic stroke, systemic embolism, and cardiovascular/unexplained death.Results The mean CHADS₂ score and CHA₂DS₂-VASc (CHADS₂ score plus 2 points for age ≥75 years and 1 point for vascular disease, age 65 to 74 years, or female sex) score were 2.8 ± 1.2 and 4.4 ± 1.7, respectively. History of hemorrhagic/bleeding tendencies (93%) was the most common reason for warfarin ineligibility. Mean duration of follow-up was 14.4 ± 8.6 months. Serious procedure- or device-related safety events occurred in 8.7% of patients (13 of 150 patients). All-cause stroke or systemic embolism occurred in 4 patients (2.3% per year): ischemic stroke in 3 patients (1.7% per year) and hemorrhagic stroke in 1 patient (0.6% per year). This ischemic stroke rate was less than that expected (7.3% per year) based on the CHADS₂ scores of the patient cohort.Conclusions LAA closure with the Watchman device can be safely performed without a warfarin transition, and is a reasonable alternative to consider for patients at high risk for stroke but with contraindications to systemic oral anticoagulation. (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology [ASAP]; NCT00851578).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“occlusion may also reduce stroke risk in patients with contraindications to OAC. 454,455”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [454]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,929
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 1×
“In the AVERROES (Apixaban Versus Acetylsalicylic Acid to Prevent Strokes in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment) study, warfarin-ineligible patients were randomly allocated to either aspirin or the factor Xa inhibitor, apixaban (21).”
MethodHolmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,242
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · cited 2×
“Clopidogrel has been reported to reduce ischemic stroke by 32% (13).”
BackgroundMethodMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Wann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,338
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 726
Wang, B., Cai, H., Wu, Y., Chen, M., Wang, C., Jiang, X., Tao, S., Zhong, Z., Zeng, J., Wang, F., et al. (2026) · EuroIntervention · doi:10.4244/eij-d-25-01168 · Cited by 2
Panaich, S., Munger, T. M., Friedman, P. A., Rihal, C. S., & Holmes, D. R. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.015 · Cited by 2
Станиславович, Ж. А. (2018) · Annaly aritmologii · doi:10.15275/annaritmol.2018.2.1 · Cited by 2
Gorgis, S., Dabbagh, M. F., Mishra, K., Ahluwalia, G., Hana, A., Fram, G. K., Dhillon, D., Lemor, A., Khan, A., Miller, D. J., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-020-00903-x · Cited by 2
Strategies to balance stroke and bleeding risk in patients with atrial fibrillation and cancer
Bagga, S., Dani, S. S., Hook, B. G., Nohria, A., & Ganatra, S. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.04.024 · Cited by 2
Armouti, A. O., Amin, S. W., & Rose, D. Z. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107618 · Cited by 2
Nasr, G., Rushworth, P. M., & Donaldson, D. M. (2024) · Cardiology Clinics · doi:10.1016/j.ccl.2024.02.018 · Cited by 2
Maksym, J., Ścisło, P., Kapłon‐Cieślicka, A., Huczek, Z., Marchel, M., Kochman, J., Zbroński, K., Opolski, G., Grabowski, M., & Mazurek, T. (2024) · Advances in Interventional Cardiology · doi:10.5114/aic.2024.140315 · Cited by 2
Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Comprehensive Review
Perswani, P., Yogarajah, R. C., Saifuddin, M., Lakhani, A., Dasi, J., Bhardwaj, V., Kumar, B., Raina, O., Fletcher, N., Jomy, G., et al. (2024) · Cureus · doi:10.7759/cureus.65347 · Cited by 2
Incidence and Predictors of Adverse Events Among Patients Awaiting Left Atrial Appendage Closure
Pieper, J. A., Bhuta, S., Poliner, M. C., Hansen, B. J., Ward, C. C., Savona, S. J., Augostini, R. S., Kalbfleisch, S. J., Afzal, M. R., Houmsse, M., et al. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16502 · Cited by 2
Real World Outcomes of Left Atrial Appendage Occlusion
Tzikas, A., Mylotte, D., Bergmann, M., & Cardiologicum Hamburg, H. (2015) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2015.10.2.109 · Cited by 2
Mechanical closure devices for atrial fibrillation
Price, M. J., & Holmes, D. R. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.06.001 · Cited by 2
Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation
Valderrábano, M., & Price, M. J. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-2-94 · Cited by 2
Hawkes, M. A., Pertierra, L., Lucci, F. R., Lereis, V. P., & Ameriso, S. F. (2016) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20150210 · Cited by 2
Berti, S., Themistoclakis, S., Santoro, G., Ponti, R. D., Danna, P., Zecchin, M., Bedogni, F., & Padeletti, L. (2014) · Giornale italiano di cardiologia · doi:10.1714/1640.17978 · Cited by 2
Amplatzer Cardiac Plug and Amulet
Saw, J. (2015) · Contemporary cardiology · doi:10.1007/978-3-319-16280-5_12 · Cited by 2
Highlights of the Year in JACC 2013
DeMaria, A. N., ADLER, E. D., Bax, J. J., Ben‐Yehuda, O., Feld, G. K., Greenberg, B., Hall, J. L., Hlatky, M. A., Lew, W. Y. W., Lima, J. A. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.002 · Cited by 2
Orale Antikoagulation und Plättchenhemmung nach Vorhofohrverschluss
Bergmann, M., & Israel, C. W. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0537-8 · Cited by 2
Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations
Dave, A. S., & Valderrábano, M. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-3-106 · Cited by 2
He, L., Du, Y., Cheng, G., & Zhang, Y. (2019) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2019.06.009 · Cited by 2
Sick, P. B. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.923 · Cited by 2
Advances in Left Atrial Appendage Occlusion Strategies.
Aryana, A., Singh, S. M., Doshi, S. K., & d’Ávila, A. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.929 · Cited by 2
Morino, Y., & Nakajima, Y. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.04.007 · Cited by 2
2021 Korean Heart Rhythm Society Guidelines for Stroke Prevention in Atrial Fibrillation
Lee, K. H., Kim, J., Shin, S. Y., & Joung, B. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.4.296 · Cited by 2
The Watchman device for preventing stroke in patients with atrial fibrillation
Zapata, J., Paamoni, A., Rinard, B., Abdou, A., Zimmer, D., & Letherer, C. C. (2021) · JAAPA · doi:10.1097/01.jaa.0000769672.18363.3f · Cited by 2
Huang, H., Chen, L., Liu, J., Wang, W., Cao, Y., Yuan, B., Tao, E., Fang, Q., Tang, L., Wang, F., et al. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16463 · Cited by 2
Freire, A. F. D., Filippini, F. B., Bignoto, T. C., de Brito, P. H. F., Nicz, P. F. G., Melo, P., Silva, R. C. E., Queiroga, M. C., Ribeiro, H. B., Procópio, A. G. M., et al. (2022) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2022.04.008 · Cited by 2
Ye, C., Han, X., Chen, Y., Liu, F., Ma, H., Yang, Y., Liu, Y., Hu, Q., Yao, Q., Xie, W., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063931 · Cited by 2
Centerline depth world for left atrial appendage orifice localization using reinforcement learning
Al, W. A., Yun, I. D., & Chun, E. J. (2023) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2023.102201 · Cited by 2
Left Atrial Appendage Closure With the Watchman™ Device
Quizhpe, A. R., Cadavid, A. F., Córdova, M. A., Vintimilla, J., Ortega, C., Vázquez, X., González, M. F., Salto, E., Astudillo, A., & Córdova, D. (2014) · Revista Brasileira de Cardiologia Invasiva (English Edition) · doi:10.1016/s2214-1235(15)30180-0 · Cited by 2
Gemma, D., Moreno, R., de Bobadilla, J. F., García, G. G., López‐Fernández, T., López-Mínguez, J. R., & Lopez-Sendon, J. L. (2016) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.01.008 · Cited by 2
Left Atrial Appendage Occlusion
Price, M. J. (2018) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2017.12.002 · Cited by 2
Indications, current adoption and future perspectives for percutaneous left atrial appendage closure
Fukutomi, M., Backer, O. D., & Søndergaard, L. (2019) · EuroIntervention · doi:10.4244/eijv14i17a293 · Cited by 2
Close the appendage, open the future
Gafoor, S. A., Sievert, H., & Matić, P. (2015) · Heart · doi:10.1136/heartjnl-2015-307452 · Cited by 2
Evolution of Stroke Prevention in Nonvalvular Atrial Fibrillation Patients∗
Lee, R. J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.030 · Cited by 2
Mazzone, P., Bella, P. E. D., & Radinovic, A. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001013 · Cited by 2
Ahmed, M. B., Sheikh, W., Parulkar, A. B., Sharma, E., Kennedy, K., Ahmed, Z., Parulkar, S. S., McCauley, B. D., Lima, F. V., & Chu, A. F. (2020) · doi:10.22541/au.159050431.16193975 · Cited by 2
Berti, S. L., Caterina, A. R. D., & Berger, R. D. (2022) · JACC Case Reports · doi:10.1016/j.jaccas.2022.04.015 · Cited by 2
Ryan, D., Girotra, T., & Feng, W. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230309100626 · Cited by 1
Ibrahim, A. M., Shalabi, L., Zreigh, S., Ramadan, S., Mourad, S., Eljadid, G. Y., Beshr, M. S., Abdelaziz, A., Elhadi, M., Sabouret, P. F., et al. (2025) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.31461 · Cited by 1
Nasr, G., Rushworth, P. M., & Donaldson, D. M. (2025) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2024.09.002 · Cited by 1
Wong, S., McCready, J. W., Cockburn, J., Broyd, C., Bagnall, T., Arunothayaraj, S., Gomes, A., Hill, A., & Hildick‐Smith, D. (2025) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70014 · Cited by 1
Diretriz Brasileira de Fibrilação Atrial – 2025
Cintra, F. D., Pisani, C. F., Rezende, A. G. D. S., Henz, B. D., Armaganijan, L., Pimentel, M., Lópes, R. D., do Nascimento, T. A., Lorga-Filho, A. M., de Albuquerque, A., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250618 · Cited by 21
Percutaneous Left Atrial Appendage Closure: Current Evidence and Procedural Insights
Mohandes, M., Shihadeh, L. A., Pernigotti, A., Torres, M., Moreno, C., Bejarano, R., Salinas, F. F., Jordi Guarinos, O., & Ferreiro, J. L. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm46003 · Cited by 1
Sénior, J. M., Borja, H., de Antioquia, U., Fernández, A., Rodríguez, A., Aldana, V. G., & de Antioquia, U. (2015) · IATREIA · doi:10.17533/udea.iatreia.v28n3a11 · Cited by 1
Pankert, M., Salaün, E., Cuisset, T., & Bonnet, J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.067 · Cited by 1
Transcatheter Left Atrial Appendage Occlusion
Don, C. W., Fuller, C. J., & Reisman, M. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.05.008 · Cited by 1
Who will benefit from anticoagulant therapy? Use of the CHADS2 score and its variants
Flaker, G., Singla, A., & Mittal, M. (2014) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s39091 · Cited by 1
Faustino, A., Paiva, L., Providencia, R. A., Cação, R., Costa, M. A. D. S., & Leitão‐Marques, A. (2013) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.06.006 · Cited by 1
Jain, T., Shah, J. J., Shah, S., & Modi, S. (2016) · Journal of Cardiovascular Ultrasound · doi:10.4250/jcu.2016.24.1.60 · Cited by 1
Interventionelle Schlaganfallprophylaxe
Rillig, A., Heeger, C.-H. H., Kück, K., & Tilz, R. R. (2015) · Herz · doi:10.1007/s00059-014-4198-7 · Cited by 1
Antiplatelet and Anticoagulant Strategies Following Left Atrial Appendage Closure
MALCOLME‐LAWES, L. C., & Kanagaratnam, P. (2015) · Contemporary cardiology · doi:10.1007/978-3-319-16280-5_19 · Cited by 1
Bonnet, G., Salaün, E., Pankert, M., Cuisset, T., & Bonnet, J.-L. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.03.003 · Cited by 1
Diagnostic et prise en charge d’une angiopathie amyloïde cérébrale sporadique
Capron, J. (2016) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2016.10.001 · Cited by 1
Update Vorhofohrverschluss 2017
Schulze, V. T., Zeus, T., & Sievert, H. (2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-122474 · Cited by 1
Aktuelle Indikationsstellung zur Vorhofohrokkluderimplantation
Jilek, C., & Lewalter, T. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0531-1 · Cited by 1
Crim, M. T., Shore, S., Lee, S. K., & Wells, B. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73709-6_13 · Cited by 1
Catheter-based left atrial appendage closure
Lunde, K., Al‐Ani, A., Bjørnerheim, R., Hervold, A., Opdahl, A., & Beitnes, J. O. (2018) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.0601 · Cited by 1
Left atrial appendage occlusion
Mandrola, J. M., & Foy, A. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000698 · Cited by 1
Left Atrial Appendage Occlusion—A Choice or a Last Resort? How to Approach the Patient
Ding, W. Y., Lip, G. Y. H., & Gupta, D. (2022) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2021.11.006 · Cited by 1
Phillips, K. P., & Kar, S. (2015) · Contemporary cardiology · doi:10.1007/978-3-319-16280-5_10 · Cited by 1
Вольфович, П. Д., Semenova, A. А., Kostritca, N. S., Merkulova, I. A., Komarov, A. L., & Merkulov, E. V. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5182 · Cited by 1
Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion
Pevsner, D. V., Rytova, Y. K., Merkulova, I., & Merkulov, E. V. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3353 · Cited by 1
Follow Up imaging After Left Atrial Appendage Occlusion–Something or Nothing and for How Long?
Nestelberger, T., Alfadhel, M., McAlister, C., & Saw, J. (2023) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2023.01.004 · Cited by 1
Optimal antiplatelet and antithrombotic regimen post‐transcatheter aortic valve replacement
Moey, M. Y. Y., Udani, K., Nifong, L., Carabello, B. A., Morris, D. L., & Shah, N. N. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.14071 · Cited by 1
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation
Pan, Y.-Q., Jin, L.-S., Qian, S., Jiang, T., Wang, Z.-N., Chen, Y.-L., Qiu, Y.-X., Wu, Y.-H., Fu, J.-Y., Li, L., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1344828 · Cited by 1
Yu, C., Li, H., Lei, C., Wang, Y., Chen, S., Zhao, Y., & Zheng, Z. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083153 · Cited by 1
Abugrin, M., Panchal, A., Aboulqassim, B., Bilal, M., & Virk, J. P. S. (2024) · CASE · doi:10.1016/j.case.2024.05.007 · Cited by 1
Santos, R., Bortoluzzi, A. L., Marinho, J. C. N., Galendi, J. S. C., & Bernardo, W. M. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100465 · Cited by 1
Tan, A., Sreedhara, S. K., Russo, M., Singer, D. E., Lauffenburger, J. C., DiCesare, E., & Lin, K. J. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.09.004 · Cited by 1
McAree, M., & Frontera, J. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-62220-5_16 · Cited by 1
Anatomical description of malformations of the neck of the left atrial appendage
Batko, J., Jakiel, R., Krawczyk‐Ożóg, A., Jaśkiewicz, K., Litwinowicz, R. A., Burysz, M., Jakiel, M., Bartuś, K., Bolechała, F., Strona, M., et al. (2024) · Clinical Anatomy · doi:10.1002/ca.24246 · Cited by 1
Stroke Prevention with Percutaneous Left Atrial Appendage Closure
Fahmy, P., & Saw, J. (2016) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s18886 · Cited by 1
Percutaneous closure of left atrial appendage for stroke prevention
Neužil, P., Mráz, T., Petrů, J., Hála, P., Mates, M., Kmoníček, P., Prokopová, M., & Reddy, V. Y. (2016) · Cor et Vasa · doi:10.1016/j.crvasa.2016.02.007 · Cited by 1
Świątkiewicz, I., Woźnicki, M., Sukiennik, A., & Kubica, J. (2016) · Medical Research Journal · doi:10.5603/mrj.2016.0008 · Cited by 1
Fernández, A., Rodríguez, A., Sénior, J. M., Aldana, V. G., & Borja, H. (2017) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.048 · Cited by 1
Left Atrial Appendage Occlusion: State of the Art
Tzikas, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-55994-0_98 · Cited by 1
Der katheterbasierte Vorhofohrverschluss – aktuelle Daten und künftige Entwicklungen
Skurk, C., Hartung, J. J., Leistner, D. M., & Landmesser, U. (2018) · Der Internist · doi:10.1007/s00108-018-0483-5 · Cited by 1
Fermeture d’auricule gauche percutanée chez le sujet âgé
Amabile, N., Elhadad, S., Roig, C., Sebag, F. A., Charles, P., & Caussin, C. (2018) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2018.10.001 · Cited by 1
Left Atrial Appendage Closure Devices for Stroke Prevention in Patients with Non-Valvular AF
McBride, D. A., Markman, T. M., Liang, J. J., & Santangeli, P. (2018) · US Cardiology Review · doi:10.15420/usc.2018.6.1 · Cited by 1
Left Atrial Appendage Closure with Double Watchman Devices: A Case Report
Alsmadi, F., Shah, M. A., & Qattea, M. B. (2019) · Journal of Structural Heart Disease · doi:10.12945/j.jshd.2019.010.18 · Cited by 1
Cardiovigilance in Atrial Fibrillation – Primordial to Quinary Prevention Intervention
Kishor, K., Bisht, D. S., & Kalra, S. (2019) · European Journal of Arrhythmia & Electrophysiology · doi:10.17925/ejae.2019.5.2.77 · Cited by 1
Bhirud, A., & Vasaiwala, S. C. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00012-3 · Cited by 1
Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
Ciuculete, D.-C., Popescu, R. A., & Dan, G. (2021) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2021-0015 · Cited by 1
Lellouche, N., Arrouasse, R., Ternacle, J., Gallet, R., Hermida, J.-S., Hamon, D., Juliard, J., Pasquié, J., Dhanjal, T., Teíger, E., et al. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01994-8 · Cited by 1
Percutaneous Left Atrial Appendage Closure: Review of Anatomy, Imaging, and Outcomes
Pour‐Ghaz, I., Heckle, M., Maturana, M. A., Seitz, M. P., Zare, P., Khouzam, R. N., & Kabra, R. (2022) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-022-00958-1 · Cited by 1
Jiang, H., Zheng, Q., Cheng, Y., Buzoianu, M., Neubrander, R., Zusterzeel, R., Farb, A. A., & Moscucci, M. M. (2023) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100541 · Cited by 1
Left Atrial Appendage Closure Device Thrombosis Despite Therapeutic Anticoagulation with Rivaroxaban
Walkin, S., Patel, K., Moustafa, A., & Grande, R. (2023) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2023.04.018 · Cited by 1
Goel, S. S., Prieto, L. R., & Kapadia, S. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-26219-4.00032-3 · Cited by 1
Secondary Prevention After Cardioembolic Stroke
Rubin, M. N., Freeman, W. D., & Aguilar, M. I. (2015) · Springer eBooks · doi:10.1007/978-3-319-17750-2_12 · Cited by 1
Percutaneous Left Atrial Appendage Closure for Non-Valvular Atrial Fibrillation
Hara, H. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0291 · Cited by 1
Percutaneous Left Atrial Appendage Closure Using the Lariat
Dukkipati, S. R., & Miller, M. A. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.10.002 · Cited by 1
DeLurgio, D. B. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.01.009 · Cited by 1
Watchman Device-Related Thrombus
Berger, R. D. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.07.003 · Cited by 1
Concerns about left atrial appendage occlusion
Stöllberger, C., & Schneider, B. (2017) · EuroIntervention · doi:10.4244/eij-d-17-00457l · Cited by 1
Biase, L. D., & Romero, J. E. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.01.014 · Cited by 1
Özeke, Ö., Çay, S., Özcan, F., Topaloğlu, S., & Aras, D. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13681 · Cited by 1
D’Ancona, G., & İnce, H. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.09.052 · Cited by 1
Lee, V. W. Y., Tsai, R. B.-C., Chow, I. H. I., Yan, B. P.-Y., Kaya, M. G., Park, J., & Lam, Y. (2015) · Clinical Trials and Regulatory Science in Cardiology · doi:10.1016/j.ctrsc.2015.08.005
Oclusão Percutânea do Apêndice Atrial Esquerdo com Prótese Watchman®
Quizhpe, A. R., Cadavid, A. F., Córdova, M. A., Vintimilla, J., Ortega, C., Vázquez, X., González, M. F., Salto, E., Astudillo, A., & Córdova, D. (2014) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/0104-1843000000011
Metadata
- Authors
- Reddy, V. Y., Möbius-Winkler, S., Miller, M. A., Neuzil, P., Schuler, G., Wiebe, J., Sick, P., & Sievert, H.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Leipzig Heart Institute (DE)
- Cardiovascular Center Frankfurt (DE)
- Krankenhaus Barmherzige Brüder (DE)
- Corresponding author
- Reddy, Vivek Y.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 61
- Issue
- 25
- Pages
- 2551-2556
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2115996784
- Cited by
- 727
- References
- 31
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 46 · 2023: 51 · 2022: 43 · 2021: 57 · 2020: 48 · 2019: 59 · 2018: 61 · 2017: 72 · 2016: 83 · 2015: 75 · 2014: 59 · 2013: 17
- FWCI
- 52.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Boston Scientific
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- left atrial appendage closure, Watchman device, non-valvular atrial fibrillation, stroke prevention, systemic embolism, CHADS2 score, CHA2DS2-VASc score, bleeding risk, procedural safety, ischemic stroke, hemorrhagic stroke, anticoagulation alternatives
- MeSH terms
- Contraindications, Clopidogrel, Administration, Oral, Aged, Aged, 80 and over, Anticoagulants, Feasibility Studies, Female, Follow-Up Studies, Humans, Male, Platelet Aggregation Inhibitors, Prospective Studies, Ticlopidine, Treatment Outcome, Atrial Appendage
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
